Clinical Trial Update: Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing telavancin to vancomycin for complicated skin and skin structure infections with emphasis on MRSA; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mrsa Infections
• Staphylococcal Skin Infection

Drugs mentioned

• Telavancin (telavancin)
• Vancomycin (vancomycin)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Staphylococcal Skin Infection | Phase 3 | Status: COMPLETED | Results posted: 2010-02-01